Healthcare -
Drug Manufacturers - General - NYSE - US
$ 97.92
-2.76 %
$ 248 B
Market Cap
20.36
P/E
MRK - COST OF REVENUE
Cost of Revenue MRK - Merck & Co., Inc.
16.1 B
LAST VALUE
8.79%
2 YEAR CAGR
3.60%
5 YEAR CAGR
-0.50%
10 YEAR CAGR